Market Overview:
The global CMO/CDMO market is expected to grow from USD XX million in 2018 to USD XX million by 2030, at a CAGR of XX%. The growth of this market can be attributed to the increasing demand for outsourcing of pharmaceutical and biotechnology products. The global CMO/CDMO market is segmented on the basis of type, application, and region. On the basis of type, the market is divided into development services, API production services, and formulation services. The development services segment is expected to grow at a higher rate during the forecast period. This can be attributed to the increasing demand for contract research and development (CR&D) activities from pharmaceutical and biotechnology companies. On the basis of application, the market is divided into pharmaceutical industry, biotechnology industry, and other applications. The pharmaceutical industry segment dominates this market owing to rising demand for outsourced products in this sector across regions.
Product Definition:
A CMO/CDMO is a company that provides contract development and manufacturing services to the pharmaceutical, biotechnology, and medical device industries. These services may include research and development (R&D), clinical trial support, process engineering and manufacturing, formulation development, analytical testing, quality control (QC), stability testing, packaging design and engineering. The importance of CMOs/CDMOs lies in their ability to provide cost-effective solutions for companies that need assistance with the commercialization of their products.
Development:
Development is the process of creating new applications, features, and functionalities for a software product. Software development involves various processes such as analysis, design, implementation or testing of computer software. Development includes activities such as designing user interfaces and developing application code. It also involves maintenance including bug fixing and enhancement of already released products/software.
API production:
API production is the process of producing application programming interface (API) for various software and hardware products. It helps in enhancing the functionality of a product by adding new features as well as provides an easy way to integrate additional applications. APIs are used majorly by software developers to access data or functionalities from one program or another program using communication protocols. The primary function of API is to provide inter-program communication at low cost with minimum latency and maximum efficiency.
Application Insights:
The pharmaceutical industry accounted for the largest revenue share of over 40% in 2017. The growing adoption of CMO/CDMO products in the pharmaceutical industry on account of increasing R&D activities and new product development is expected to drive the global market growth over the forecast period.
The biotechnology segment is anticipated to witness a lucrative CAGR during the forecast period owing to increase investments in research & development activities and new product launches. Increasing government support for biotechnology companies as well as favorable regulations aimed at promoting innovation are further expected to propel growth during this study period. CMOs play an important role in formulating drugs with improved performance characteristics that meet unmet medical needs while reducing adverse effects associated with other drug formulations or biological products developed by other methods (i.e., non-clinical).
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of CROs and CMOs, along with favorable government policies, is expected to drive this regional market over the forecast period. In addition, increasing R&D expenditure by companies as well as governments is also expected to propel growth during the same period.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and growing investments by pharmaceutical companies for drug discovery & development activities in this region coupled with rising awareness about advanced medicines among patients. Moreover, economic development in countries like India and China has improved access of medicine for patients which will further boost revenue generation from global centers throughout 2018-2030 time frame.
Moreover, Latin America has also been witnessing significant developments due to increased focus on biologics production techniques leading towards high demand for cMOs/CDMOs across countries such as Brazil & Argentina etc.
Growth Factors:
- Increasing demand for biologics and biosimilars: The global market for biologics is expected to grow at a CAGR of over 10% from 2016 to 2020. This is largely due to the increasing prevalence of chronic diseases, such as cancer and diabetes, and the rising demand for novel therapies. The market for biosimilars is also expected to grow rapidly in the next few years as more countries adopt these drugs.
- Growing focus on personalized medicine: Personalized medicine involves tailoring treatments based on an individual’s genetic makeup or lifestyle factors. This approach is becoming increasingly popular due to its potential benefits, such as improved efficacy and reduced side effects. As a result, the CMO/CDMO market is expected to benefit from increased demand for customized therapies in the coming years.
- Rising R&D spending by pharmaceutical companies: Pharmaceutical companies are investing more money into R&D in order to develop new drugs and improve their product pipelines. This trend is likely to continue in the foreseeable future, resulting in increased demand for contract manufacturing services from CMOs/CDMOs .
Scope Of The Report
Report Attributes
Report Details
Report Title
CMO/CDMO Market Research Report
By Type
Development, API production, Formulation
By Application
Pharmaceutical Industry, Biotechnology, Other
By Companies
Recipharm, AMRI3, Patheon, Aenova, Catalent, Amatsigroup, WuXi PharmaTech, Strides Shasun, Piramal, Siegfried
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
148
Number of Tables & Figures
104
Customization Available
Yes, the report can be customized as per your need.
Global CMO/CDMO Market Report Segments:
The global CMO/CDMO market is segmented on the basis of:
Types
Development, API production, Formulation
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Industry, Biotechnology, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Recipharm
- AMRI3
- Patheon
- Aenova
- Catalent
- Amatsigroup
- WuXi PharmaTech
- Strides Shasun
- Piramal
- Siegfried
Highlights of The CMO/CDMO Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Development
- API production
- Formulation
- By Application:
- Pharmaceutical Industry
- Biotechnology
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the CMO/CDMO Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
CMO/CDMO is a term used in marketing and advertising to describe the role of a Chief Marketing Officer (CMO) or Chief Digital Officer (CDO). The CMO or CDO is responsible for developing and executing the overall marketing strategy for their organization, while also leading digital efforts.
Some of the major companies in the cmo/cdmo market are Recipharm, AMRI3, Patheon, Aenova, Catalent, Amatsigroup, WuXi PharmaTech, Strides Shasun, Piramal, Siegfried.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 CMO/CDMO Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 CMO/CDMO Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 CMO/CDMO Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the CMO/CDMO Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global CMO/CDMO Market Size & Forecast, 2018-2028
4.5.1 CMO/CDMO Market Size and Y-o-Y Growth
4.5.2 CMO/CDMO Market Absolute $ Opportunity
Chapter 5 Global CMO/CDMO Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 CMO/CDMO Market Size Forecast by Type
5.2.1 Development
5.2.2 API production
5.2.3 Formulation
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global CMO/CDMO Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 CMO/CDMO Market Size Forecast by Applications
6.2.1 Pharmaceutical Industry
6.2.2 Biotechnology
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global CMO/CDMO Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 CMO/CDMO Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America CMO/CDMO Analysis and Forecast
9.1 Introduction
9.2 North America CMO/CDMO Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America CMO/CDMO Market Size Forecast by Type
9.6.1 Development
9.6.2 API production
9.6.3 Formulation
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America CMO/CDMO Market Size Forecast by Applications
9.10.1 Pharmaceutical Industry
9.10.2 Biotechnology
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe CMO/CDMO Analysis and Forecast
10.1 Introduction
10.2 Europe CMO/CDMO Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe CMO/CDMO Market Size Forecast by Type
10.6.1 Development
10.6.2 API production
10.6.3 Formulation
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe CMO/CDMO Market Size Forecast by Applications
10.10.1 Pharmaceutical Industry
10.10.2 Biotechnology
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific CMO/CDMO Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific CMO/CDMO Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific CMO/CDMO Market Size Forecast by Type
11.6.1 Development
11.6.2 API production
11.6.3 Formulation
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific CMO/CDMO Market Size Forecast by Applications
11.10.1 Pharmaceutical Industry
11.10.2 Biotechnology
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America CMO/CDMO Analysis and Forecast
12.1 Introduction
12.2 Latin America CMO/CDMO Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America CMO/CDMO Market Size Forecast by Type
12.6.1 Development
12.6.2 API production
12.6.3 Formulation
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America CMO/CDMO Market Size Forecast by Applications
12.10.1 Pharmaceutical Industry
12.10.2 Biotechnology
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) CMO/CDMO Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) CMO/CDMO Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) CMO/CDMO Market Size Forecast by Type
13.6.1 Development
13.6.2 API production
13.6.3 Formulation
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) CMO/CDMO Market Size Forecast by Applications
13.10.1 Pharmaceutical Industry
13.10.2 Biotechnology
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 CMO/CDMO Market: Competitive Dashboard
14.2 Global CMO/CDMO Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Recipharm
14.3.2 AMRI3
14.3.3 Patheon
14.3.4 Aenova
14.3.5 Catalent
14.3.6 Amatsigroup
14.3.7 WuXi PharmaTech
14.3.8 Strides Shasun
14.3.9 Piramal
14.3.10 Siegfried
